Abstract 13280: Inhibition of miR-33a and b in Non-Human Primates Raises Plasma HDL Cholesterol and Reduces VLDL Triglycerides

Ryan E. Temel(University of Kentucky), Kathryn J. Moore(New York University), Janine M. van Gils(Leiden University Medical Center), Carlos Fernández‐Hernando(Yale University), Stephanie Marshall(Wake Forest University), Katey J. Rayner(University of Ottawa), Edward A. Fisher(Mount Sinai Hospital), Christine Esau(Ionis Pharmaceuticals (United States)), Cynthia J. Lees(Wake Forest University), Allison L. McDaniel(Wake Forest University)
Circulation
November 22, 2011
Cited by 0

Related Papers

Macrophage Activation and Polarization: Nomenclature and Experimental Guidelines
|Immunity|2014|6.2k
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
|Nature|2010|4k
miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting
|Cell Metabolism|2006|2.1k
Lipoprotein(a) as a cardiovascular risk factor: current status
|European Heart Journal|2010|1.8k
CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer
|Nature Immunology|2009|1.5k